Cipla Cipla The USFDA has conducted an inspection at the Company’s manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483 Cipla Cipla The USFDA has conducted an inspection at the Company’s manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483

Cipla

Cipla The USFDA has conducted an inspection at the Company's manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483 Cipla

Cipla The USFDA has conducted an inspection at the Company’s manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483

Please follow and like us: